Inappropriate secretion of thyroid-stimulating hormone.
作者信息
Khandwala Hasnain, Lee Cheong
机构信息
Division of Endocrinology, University of Saskatchewan, Saskatoon, Sask.
出版信息
CMAJ. 2006 Aug 15;175(4):351. doi: 10.1503/cmaj.060266.
Abstract
摘要
相似文献
1
Inappropriate secretion of thyroid-stimulating hormone.促甲状腺激素分泌不当。
CMAJ. 2006 Aug 15;175(4):351. doi: 10.1503/cmaj.060266.
2
[Hyperthyroidism in TSH-producing hypophyseal adenoma].[促甲状腺激素分泌型垂体腺瘤所致甲状腺功能亢进症]
Dtsch Med Wochenschr. 1997 Feb 7;122(6):150-5. doi: 10.1055/s-2008-1047589.
3
[Hyperthyroidism caused by a TSH producing pituitary adenoma].[促甲状腺激素分泌型垂体腺瘤所致甲状腺功能亢进症]
Acta Med Austriaca. 1999;26(1):32-6.
4
Hoarding disorder secondary to pituitary adenoma: a case study.垂体腺瘤继发的囤积障碍：一例病例报告
Arq Neuropsiquiatr. 2016 May 20;74(7):601-2. doi: 10.1590/0004-282X20160034.
5
Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide).一名患有促甲状腺素分泌型大腺瘤的不孕女性经生长抑素类似物（奥曲肽）治疗后成功妊娠。
J Clin Endocrinol Metab. 1996 Mar;81(3):1164-8. doi: 10.1210/jcem.81.3.8772594.
6
A case of Schmidt syndrome accompanied by a pituitary adenoma.1例伴有垂体腺瘤的施密特综合征。
Endocr J. 1996 Oct;43(5):495-502. doi: 10.1507/endocrj.43.495.
7
Preoperative long-acting octreotide treatment for invasive thyrotropin-secreting pituitary macroadenoma after previous radioiodine thyroid ablation.既往放射性碘甲状腺消融术后侵袭性促甲状腺素分泌型垂体大腺瘤的术前长效奥曲肽治疗。
J Clin Neurosci. 2014 Feb;21(2):340-2. doi: 10.1016/j.jocn.2013.02.038. Epub 2013 Aug 16.
8
Reduction in size of a thyrotropin- and gonadotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog).用醋酸奥曲肽（生长抑素类似物）治疗促甲状腺激素和促性腺激素分泌型垂体腺瘤后瘤体缩小
J Clin Endocrinol Metab. 1992 Mar;74(3):690-4. doi: 10.1210/jcem.74.3.1740506.
9
10
Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature.醋酸奥曲肽对促甲状腺素分泌性腺瘤的影响：两例报告并文献复习
Endocr Regul. 1999 Dec;33(4):169-74.
引用本文的文献
1
The clinical characteristics and gene mutations associated with thyroid hormone resistance syndrome coexisting with pituitary tumors.与垂体瘤共存的甲状腺激素抵抗综合征的临床特征和基因突变。
Front Endocrinol (Lausanne). 2023 Feb 10;14:1131044. doi: 10.3389/fendo.2023.1131044. eCollection 2023.
2
Challenging diagnosis of resistance to thyroid hormone in a patient with pituitary adenoma.垂体腺瘤患者甲状腺激素抵抗的诊断难题
BMJ Case Rep. 2019 Jul 19;12(7):e229430. doi: 10.1136/bcr-2019-229430.
3
Hyperthyroidism caused by a pituitary adenoma.垂体腺瘤引起的甲状腺功能亢进症。
CMAJ. 2011 Aug 9;183(11):E757. doi: 10.1503/cmaj.101244. Epub 2011 Apr 4.
本文引用的文献
1
Resistance to thyroid hormone.对甲状腺激素的抵抗
Rev Endocr Metab Disord. 2000 Jan;1(1-2):97-108. doi: 10.1023/a:1010072605757.
2
Thyrotropin-secreting pituitary tumors.促甲状腺激素分泌型垂体瘤。
Endocr Rev. 1996 Dec;17(6):610-38. doi: 10.1210/edrv-17-6-610.
3
Inappropriate secretion of thyrotropin by the pituitary.垂体促甲状腺激素分泌异常。
Horm Res. 1987;26(1-4):79-99. doi: 10.1159/000180687.
Zotero 插件